FibroGen, Inc(FGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FGEN FibroGen, Inc

劳工日休市 01-07 16:00:00 EST

9.71

+0.00

0.00%

最高9.71	最低9.71	成交量0.00
今开9.71	昨收9.71	日振幅0.00%
总市值3,928万	流通市值3,519万	总股本404.54万
成交额32.36万	换手率0.00%	流通股本362.37万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FGEN","market":"US","secType":"STK","nameCN":"FibroGen, Inc","latestPrice":9.71,"timestamp":1767819600000,"preClose":9.71,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":3623701,"shares":4045445,"eps":53.37957,"marketStatus":"劳工日休市","change":0,"latestTime":"01-07 16:00:00 EST","open":9.71,"high":9.71,"low":9.71,"amount":323605.91832,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":53.37957,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"symbolChange":{"newSymbol":"KYNB","executeDate":"2026-01-08"},"adr":0,"adrRate":0,"listingDate":1415941200000,"exchange":"NASDAQ","adjPreClose":9.71,"volumeRatio":0},"requestUrl":"/m/hq/s/FGEN","defaultTab":"news","newsList":[{"id":"2518273061","title":"珐博进盘中异动 股价大涨5.58%报0.392美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518273061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518273061?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:31","pubTimestamp":1741617105,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时31分，珐博进股票出现波动，股价快速上涨5.58%。截至发稿，该股报0.392美元/股，成交量21.9172万股，换手率0.22%，振幅7.01%。珐博进股票所在的生物技术行业中，整体涨幅为0.08%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223145964044f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223145964044f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517165573","title":"珐博进盘中异动 股价大跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517165573?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271527,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，珐博进股票出现异动，股价大幅下挫5.76%。截至发稿，该股报0.371美元/股，成交量4.1618万股，换手率0.04%，振幅0.00%。珐博进股票所在的生物技术行业中，整体跌幅为0.66%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208989eb426&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208989eb426&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517923596","title":"珐博进盘中异动 下午盘股价大涨5.52%报0.380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517923596?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:02","pubTimestamp":1741201328,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时02分，珐博进股票出现异动，股价大幅拉升5.52%。截至发稿，该股报0.380美元/股，成交量43.399万股，换手率0.43%，振幅7.21%。珐博进股票所在的生物技术行业中，整体涨幅为1.79%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030208989d8020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030208989d8020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","FGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516167787","title":"珐博进盘中异动 早盘股价大跌8.90%报0.347美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516167787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516167787?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:42","pubTimestamp":1741099367,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时42分，珐博进股票出现波动，股价急速下挫8.90%。截至发稿，该股报0.347美元/股，成交量24.1388万股，换手率0.24%，振幅4.70%。珐博进股票所在的生物技术行业中，整体涨幅为0.08%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422424896394823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422424896394823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","FGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516331637","title":"珐博进盘中异动 股价大跌5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516331637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516331637?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:57","pubTimestamp":1741013876,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时57分，珐博进股票出现波动，股价大幅下挫5.90%。截至发稿，该股报0.384美元/股，成交量24.081万股，换手率0.24%，振幅7.10%。珐博进股票所在的生物技术行业中，整体涨幅为0.02%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225756abe63c05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225756abe63c05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","FGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320221","title":"珐博进盘中异动 大幅跳水6.72%报0.376美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514320221?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753314,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，珐博进股票出现异动，股价快速下挫6.72%。截至发稿，该股报0.376美元/股，成交量17.6487万股，换手率0.18%，振幅3.37%。珐博进股票所在的生物技术行业中，整体涨幅为0.16%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223515abe0ebca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223515abe0ebca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514290389","title":"珐博进盘中异动 早盘快速跳水5.13%报0.437美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514290389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514290389?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:57","pubTimestamp":1740668246,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时57分，珐博进股票出现波动，股价快速下挫5.13%。截至发稿，该股报0.437美元/股，成交量36.6828万股，换手率0.36%，振幅7.82%。珐博进股票所在的生物技术行业中，整体涨幅为1.01%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225726a2568096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225726a2568096&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514086168","title":"珐博进盘中异动 快速跳水5.74%报0.471美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514086168?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:52","pubTimestamp":1740595961,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时52分，珐博进股票出现波动，股价快速下挫5.74%。截至发稿，该股报0.471美元/股，成交量126.876万股，换手率1.26%，振幅7.44%。珐博进股票所在的生物技术行业中，整体跌幅为0.65%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227025242abde2670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227025242abde2670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","FGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090681","title":"珐博进股价重挫21.46% 市值跌985.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090681?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:33","pubTimestamp":1740493984,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时33分，珐博进股票出现异动，股价急速下跌21.46%。截至发稿，该股报0.456美元/股，成交量79.7398万股，换手率0.79%，振幅5.83%。珐博进股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为756.21%、468.17%、239.78%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Tarsus Pharmaceuticals, Inc.，振幅分别为20.51%、14.67%、11.68%。迄今为止，珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223304962ff2ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223304962ff2ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722768","title":"珐博进盘中异动 大幅跳水9.39%报0.640美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513722768?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407532,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，珐博进股票出现异动，股价急速跳水9.39%。截至发稿，该股报0.640美元/股，成交量50.136万股，换手率0.50%，振幅1.09%。珐博进股票所在的生物技术行业中，整体跌幅为0.09%。迄今为止，珐博进几乎所有的收入都来自其合作协议。根据协议条款，珐博进将获得8500万美元的企业价值，以及交易交割时珐博进中国持有的约7500万美元现金，总计约1.6亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223213abdb0e04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223213abdb0e04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513965342","title":"珐博进盘中异动 大幅下挫8.12%报0.710美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513965342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513965342?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148300,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，珐博进股票出现异动，股价快速跳水8.12%。截至发稿，该股报0.710美元/股，成交量225.813万股，换手率2.24%，振幅1.84%。珐博进股票所在的生物技术行业中，整体涨幅为0.33%。迄今为止，珐博进几乎所有的收入都来自其合作协议。根据协议条款，珐博进将获得8500万美元的企业价值，以及交易交割时珐博进中国持有的约7500万美元现金，总计约1.6亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223141abd7af87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223141abd7af87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512464104","title":"阿斯利康将以约1.6亿美元的价格收购珐博进中国","url":"https://stock-news.laohu8.com/highlight/detail?id=2512464104","media":"金吾资讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512464104?lang=zh_cn&edition=full","pubTime":"2025-02-20 19:56","pubTimestamp":1740052582,"startTime":"0","endTime":"0","summary":"金吾财讯 | 2月20日，阿斯利康(AZN)与珐博进有限公司达成一项收购协议，阿斯利康将以约 1.6 亿美元的价格收购珐博进中国。按照协议内容，珐博进可获得 8500 万美元的企业价值，加上交易交割时珐博进中国持有的约 7500 万美元现金，总计约 1.6 亿美元。该交易预计在 2025 年中期完成交割，但具体时间取决于包括中国监管审查等在内的常规交割条件。一旦交割完成，阿斯利康将拥有罗沙司他在中国的全部权利，而珐博进则保留其在美国以及未授权给安斯泰来的市场对罗沙司他的权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220195644988c4584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220195644988c4584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2456880835.USD","LU0109394709.USD","BK4588","FGEN","LU0320765992.SGD","BK4585","LU1829250122.USD","LU0889565916.HKD","BK4568","LU2417539215.USD","LU2236285917.USD","LU2462157665.USD","AZN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512827334","title":"珐博进盘中异动 急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512827334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512827334?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:02","pubTimestamp":1739984542,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时02分，珐博进股票出现异动，股价急速跳水5.04%。截至发稿，该股报0.556美元/股，成交量32.4696万股，换手率0.32%，振幅4.60%。珐博进股票所在的生物技术行业中，整体涨幅为0.38%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200102229628e57f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200102229628e57f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165521","title":"珐博进盘中异动 大幅上涨5.14%报0.583美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165521?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:42","pubTimestamp":1739889763,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时42分，珐博进股票出现异动，股价快速拉升5.14%。截至发稿，该股报0.583美元/股，成交量8.8429万股，换手率0.09%，振幅5.10%。珐博进股票所在的生物技术行业中，整体涨幅为0.55%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224243abd3b1c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224243abd3b1c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","PULM","FGEN","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692959","title":"珐博进盘中异动 大幅拉升5.61%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511692959?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:01","pubTimestamp":1739548909,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日00时01分，珐博进股票出现波动，股价急速上涨5.61%。截至发稿，该股报0.550美元/股，成交量29.7719万股，换手率0.30%，振幅4.93%。机构评级方面，在所有2家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。珐博进股票所在的生物技术行业中，整体跌幅为0.60%。迄今为止，珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021500014996232ffc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021500014996232ffc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511252935","title":"珐博进盘中异动 股价大涨5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511252935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511252935?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:42","pubTimestamp":1739457767,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时42分，珐博进股票出现异动，股价快速拉升5.92%。截至发稿，该股报0.483美元/股，成交量2.7529万股，换手率0.03%，振幅2.79%。珐博进股票所在的生物技术行业中，整体跌幅为0.17%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322424798842e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322424798842e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","FGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510033000","title":"珐博进盘中异动 股价大跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510033000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510033000?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:51","pubTimestamp":1739296266,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时51分，珐博进股票出现波动，股价急速下跌5.62%。截至发稿，该股报0.470美元/股，成交量26.3015万股，换手率0.26%，振幅7.00%。珐博进股票所在的生物技术行业中，整体跌幅为1.79%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212015106abcb30d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212015106abcb30d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","FGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510869631","title":"珐博进盘中异动 快速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510869631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510869631?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:20","pubTimestamp":1739200830,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时20分，珐博进股票出现波动，股价大幅跳水5.01%。截至发稿，该股报0.478美元/股，成交量6.7236万股，换手率0.07%，振幅4.37%。珐博进股票所在的生物技术行业中，整体跌幅为0.13%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210232030abc9b0af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210232030abc9b0af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","FGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509235708","title":"珐博进盘中异动 早盘股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509235708?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:08","pubTimestamp":1738771682,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时08分，珐博进股票出现异动，股价急速拉升5.57%。截至发稿，该股报0.489美元/股，成交量29.2001万股，换手率0.29%，振幅6.46%。珐博进股票所在的生物技术行业中，整体涨幅为1.33%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206000802a23a920b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206000802a23a920b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509266495","title":"珐博进盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509266495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509266495?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:01","pubTimestamp":1738699260,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时01分，珐博进股票出现异动，股价急速跳水5.03%。截至发稿，该股报0.452美元/股，成交量49.3432万股，换手率0.49%，振幅6.48%。珐博进股票所在的生物技术行业中，整体涨幅为1.51%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205040100a2396583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205040100a2396583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","FGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fibrogen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.1415},{"period":"ytd","weight":0.1059}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fibrogen, Inc.于1993年在美国特拉华州注册成立。该公司是一家生物制药公司，专注于癌症生物学和贫血前沿领域的新疗法开发。该公司正在开发FG-3246，这是一种潜在的靶向CD46的first-in-class抗体药物偶联物，用于治疗转移性去势抵抗性前列腺癌和潜在的其他癌症。该计划还包括FG-3180的开发，这是一种相关的CD46靶向正电子发射断层扫描生物标志物和显像剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.189118},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.032668},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.060681},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.133734},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.039352},{"month":6,"riseRate":0.636364,"avgChangeRate":-0.001658},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.034699},{"month":8,"riseRate":0.363636,"avgChangeRate":0.01162},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.009378},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.070226},{"month":11,"riseRate":0.727273,"avgChangeRate":0.07854},{"month":12,"riseRate":0.636364,"avgChangeRate":0.096082}],"exchange":"NASDAQ","name":"FibroGen, Inc","nameEN":"FibroGen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FibroGen, Inc(FGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供FibroGen, Inc(FGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"FibroGen, Inc,FGEN,FibroGen, Inc股票,FibroGen, Inc股票老虎,FibroGen, Inc股票老虎国际,FibroGen, Inc行情,FibroGen, Inc股票行情,FibroGen, Inc股价,FibroGen, Inc股市,FibroGen, Inc股票价格,FibroGen, Inc股票交易,FibroGen, Inc股票购买,FibroGen, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FibroGen, Inc(FGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供FibroGen, Inc(FGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}